title: Health policy and cost-effectiveness analysis: yes we can. Yes we must.
authors.forename: John B
authors.initials: JB
authors.lastname: Wong
authors.forename: Cynthia
authors.initials: C
authors.lastname: Mulrow
authors.forename: Harold C
authors.initials: HC
authors.lastname: Sox
mesh_terms: D003327:Coronary Disease / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D006291:Health Policy / Q000191:economics*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics; D011322:Primary Prevention / Q000191:economics; D014481:United States
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors